MedPath

Early Closure of Temporary Ileostomy

Not Applicable
Completed
Conditions
Rectal Cancer
Interventions
Procedure: Standard reversal of temporary ileostomy
Procedure: Early reversal of temporary ileostomy
Registration Number
NCT01287637
Lead Sponsor
Herlev Hospital
Brief Summary

The study is being conducted as a prospective randomized controlled multicenter study of patients with a temporary ileostomy due to rectal cancer. The study will be conducted in hospitals in Denmark and Sweden under the framework of the Scandinavian Surgical Outcomes Group (www.ssorg.net).

The study investigates the effect of reversing a temporary ileostomy after 8-13 days instead of later reversal more than 12 weeks after surgery.

Detailed Description

After creation of the temporary ileostomy patients are included and are randomized to two groups. Patients in the intervention group will have the stoma closed 8-13 days after stoma creation and will be compared to patients in the control group where the stoma is closed after a minimum of 12 weeks (standard treatment in Denmark and Sweden).

Before randomization the eligible patients undergo a CT of the rectum to visualise the anastomosis and possible leakage. Furthermore, the local investigators may choose to supplement the CT with a rectoscopy.

The research group includes 89 patients over an expected period of 4 years. Both groups are examined for postoperative complications as well as stoma-related complications at discharge and 3, 6 and 12 months after stoma creation.

The research group also examines the impact on patients´ health-related quality of life at 3, 6 and 12 months after stoma creation.

Finally the socio-economic effect in both groups will be analyzed and compared 6 and 12 months after stoma creation.

An interim analysis is planned for safety as well as recalculation of statistical power.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
89
Inclusion Criteria
  • Patients with a temporary ileostomy after low anterior resection because of rectal cancer
  • Patients, who are physically and mentally fit to undergo surgery within 8-13 days
Exclusion Criteria
  • Patients whose stoma is not reversible
  • Patients with diabetes
  • Patients being treated with Steroids
  • Patients with communicative problems
  • Patients with expected compliance issues

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Control groupStandard reversal of temporary ileostomyStandard reversal of temporary ileostomy
Early reversal groupEarly reversal of temporary ileostomyEarly reversal of temporary ileostomy
Primary Outcome Measures
NameTimeMethod
Postsurgical morbidity6 months after inclusion

Patients are scored according to the Clavien-Dindo Classification of Surgical Complications.

Postsurgical morbidity.12 months after inclusion-

Patients are scored according to the Clavien-Dindo Classification of Surgical Complications.

Secondary Outcome Measures
NameTimeMethod
Socio-economic effect of early reversal of temporary ileostomyThe investigators assess and analyze the economic effect 12 months after inclusion

The investigators register all admissions to hospital and out-patient clinics up to 12 months after the operation. Furthermore, the investigators apply patients´self-reported data on visits to general practitioner, primary care nurses and other health care workers in primary care.

Quality of lifeQuality of life is assessed at 12 months after inclusion

Patients quality of life is assessed with three questionnaires that supplement each other: Short Form 36 (SF-36), Ostomy Adjustment Scale (OAS) and European Organization for the Treatment of Cancer CR30+CR29 (EORTC QLQ-CR30+CR29)

Trial Locations

Locations (1)

Herlev Hospital, University of Copenhagen

🇩🇰

Herlev, Denmark

© Copyright 2025. All Rights Reserved by MedPath